 Macrolide antibiotics |
| OF THE INVENTION The following reaction Schemes illustrate the preparation of the compounds of the ... |
|
| Processes, apparatus and compositions for characterizing nucleotide sequences based on K-tuple analysis |
| The aforementioned and other objects are attained by the invention, which provides in one aspect a ... |
|
| Variant of LAV viruses |
| In accordance with this invention, a new virus has been discovered that is responsible for diseases ... |
|
| Anti-arthritic preparation |
| OF THE INVENTION The term "arthritis" relates generally to a class of disorders characterized by ... |
|
| Complexes of technetium-99m with propylene amine oximes |
| We claim: 1. A lipophilic macrocyclic complex, useful as a diagnostic radiopharmaceutical, of ... |
|
| .sup.99m Tc labeled liposomes |
| Stable .sup.99m Tc-labeled liposomes and .sup.99m Tc labeled liposome-encapsulated protein and ... |
|
| Method of reducing immunogenicity |
| I claim: 1. A method of reducing immunogenicity of avidin, comprising the step of coupling the ... |
|
| Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| We claim: 1. In a method for targeting a diagnostic or therapeutic metal ion to a lesion in a ... |
|
| Lymphatic delivery composition |
| We claim: 1. A composition capable of delivering an active agent to the lymphatic system comprising ... |
|
|
Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for suppressing side-effect of radiotherapy and chemotherapy
| Details |
Inventors: Xu, Qiwang; Liu, Junkang; Yuan, Zetao;
Assignee: Third Military Medical University, Chinese People's Liberation Army, P.R. of China (Chongqing, CN); Bio-Wave Institute of Suzhou Hi-Tech New District Corporation, LTD (Jiangsu, CN); Beijing Sino-Hongkong Dafu Science & Technology of Biowave Co., Ltd. (Bei
Primary Examiner: Wilson; James O.
Assistant Examiner: McIntosh, III; Traviss C.
Attorney, Agent or Firm: Ladas & Parry LLP
The present invention has disclosed a use of N-acetyl-D-glucosamine in the manufacture of a medicament for inhibiting the side effect of radio-chemical therapy, the medicament with N-acetyl-D-glucosamine as main active component can be used to inhibit the side effect of radio-chemical therapy of cancer patients, with an effective rate up to 85%. |
|
DETAILED DESCRIPTION The invention claimed is: 1.
A method for treating a cancer patient who is undergoing or has undergone a radiation therapy or chemotherapy treatment, the method comprising administering to said patient a medicament comprising N-acetyl-D-glucosamine of the following formula (I) or a pharmaceutically acceptable salt thereof: ##STR2## said medicament being administered to the patient in an amount effective to reduce the incidence or severity of at least one side effect of said radiation therapy or chemotherapy treatment.
2.
The method according to claim 1, wherein the at least one side effect is selected from the group consisting of nausea, vomiting, decreased energy, diminished appetite, cachexia and immune dysfunction.
3.
The method according to claim 2, wherein the medicament is administered to the patient after said radiation therapy or chemotherapy treatment.
4.
The method according to claim 2, wherein the medicament is administered to the patient with said radiation therapy or chemotherapy treatment.
5.
The method according to claim 2, wherein the medicament is administered to the patient before and with said radiation therapy or chemotherapy treatment.
6.
The method according to claim 1, wherein the at least one side effect is selected from the group consisting of lack of energy, sleeplessness, palpitation, diminished appetite and feelings of weakness.
7.
The method according to claim 6, wherein the medicament is administered to the patient after said radiation therapy or chemotherapy treatment.
8.
The method according to claim 6, wherein the medicament is administered to the patient with said radiation therapy or chemotherapy treatment.
9.
The method according to claim 6, wherein the medicament is administered to the patient before and with said radiation therapy or chemotherapy treatment.
10.
The method according to claim 1, wherein the medicament is administered to the patient orally, intravenously or intramuscularly.
11.
The method according to claim 1, wherein the patient is an adult patient and the medicament is administered to the adult patient at a dosage of 200-1000 mg N-acetyl-D-glucosamine
|
|
Gene Therapy 
